Fondazione Italiana Linfomi - Ets

This study tested whether adding the drug venetoclax to standard chemotherapy (R-BAC) helps older patients with high-risk mantle cell lymphoma live longer without their cancer getting worse. The trial involved 141 patients aged 65 and older (or younger if unable to have a transpl…

This study followed 127 people with diffuse large B-cell lymphoma who were receiving standard chemotherapy (R-CHOP or similar). The goal was to track how often heart problems occurred during treatment. No new drug or therapy was tested; researchers simply observed and recorded he…

This study looked back at the medical records of 633 adults with primary mediastinal large B-cell lymphoma (PMBCL) treated between 2007 and 2019. The goal was to understand how well different treatments worked, how often the disease came back, and what side effects occurred. No n…

This study looked at 100 adults with cutaneous T-cell lymphoma (CTCL) who had already tried at least one other treatment. Researchers wanted to see how well the drug mogamulizumab works in everyday medical practice, not just in controlled trials. They measured how many patients h…

This study looked at 300 people with Waldenström's macroglobulinemia or a related early condition. Researchers checked if genetic mutations found in bone marrow could also be detected in blood or urine samples. The goal was to see if these simpler, less painful tests could reliab…

This study looked at whether PET scans can give doctors more accurate information about mantle cell lymphoma, a rare blood cancer, compared to standard CT scans and bone marrow biopsies. Researchers reviewed past data from 200 patients to see if PET scans could help predict how t…